BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36050483)

  • 1. ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung.
    Nobre AR; Dalla E; Yang J; Huang X; Wullkopf L; Risson E; Razghandi P; Anton ML; Zheng W; Seoane JA; Curtis C; Kenigsberg E; Wang J; Aguirre-Ghiso JA
    Nat Cancer; 2022 Oct; 3(10):1165-1180. PubMed ID: 36050483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MacroH2A impedes metastatic growth by enforcing a discrete dormancy program in disseminated cancer cells.
    Sun D; Singh DK; Carcamo S; Filipescu D; Khalil B; Huang X; Miles BA; Westra W; Sproll KC; Hasson D; Bernstein E; Aguirre-Ghiso JA
    Sci Adv; 2022 Dec; 8(48):eabo0876. PubMed ID: 36459552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
    Ramamoorthi G; Kodumudi K; Gallen C; Zachariah NN; Basu A; Albert G; Beyer A; Snyder C; Wiener D; Costa RLB; Czerniecki BJ
    Semin Cancer Biol; 2022 Jan; 78():78-89. PubMed ID: 33626407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of early dissemination and metastasis in Her2
    Harper KL; Sosa MS; Entenberg D; Hosseini H; Cheung JF; Nobre R; Avivar-Valderas A; Nagi C; Girnius N; Davis RJ; Farias EF; Condeelis J; Klein CA; Aguirre-Ghiso JA
    Nature; 2016 Dec; 540(7634):588-592. PubMed ID: 27974798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63.
    Liu Y; Zhang P; Wu Q; Fang H; Wang Y; Xiao Y; Cong M; Wang T; He Y; Ma C; Tian P; Liang Y; Qin LX; Yang Q; Yang Q; Liao L; Hu G
    Nat Commun; 2021 Sep; 12(1):5232. PubMed ID: 34475402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth.
    Weidenfeld K; Schif-Zuck S; Abu-Tayeh H; Kang K; Kessler O; Weissmann M; Neufeld G; Barkan D
    Oncotarget; 2016 Nov; 7(44):71362-71377. PubMed ID: 27655685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal changes in the aged lung induce an emergence from melanoma dormancy.
    Fane ME; Chhabra Y; Alicea GM; Maranto DA; Douglass SM; Webster MR; Rebecca VW; Marino GE; Almeida F; Ecker BL; Zabransky DJ; Hüser L; Beer T; Tang HY; Kossenkov A; Herlyn M; Speicher DW; Xu W; Xu X; Jaffee EM; Aguirre-Ghiso JA; Weeraratna AT
    Nature; 2022 Jun; 606(7913):396-405. PubMed ID: 35650435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How much do we know about the metastatic process?
    Rodriguez-Tirado C; Sosa MS
    Clin Exp Metastasis; 2024 Mar; ():. PubMed ID: 38520475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition.
    Taylor DP; Clark A; Wheeler S; Wells A
    Breast Cancer Res Treat; 2014 Apr; 144(3):551-60. PubMed ID: 24610032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?
    Weidenfeld K; Barkan D
    Front Oncol; 2018; 8():381. PubMed ID: 30258818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer.
    Wendt MK; Schiemann BJ; Parvani JG; Lee YH; Kang Y; Schiemann WP
    Oncogene; 2013 Apr; 32(16):2005-15. PubMed ID: 22710711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glypican-3 (GPC3) inhibits metastasis development promoting dormancy in breast cancer cells by p38 MAPK pathway activation.
    Guereño M; Delgado Pastore M; Lugones AC; Cercato M; Todaro L; Urtreger A; Peters MG
    Eur J Cell Biol; 2020 Aug; 99(6):151096. PubMed ID: 32800275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro system to study tumor dormancy and the switch to metastatic growth.
    Barkan D; Green JE
    J Vis Exp; 2011 Aug; (54):. PubMed ID: 21860375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.
    Barkan D; Kleinman H; Simmons JL; Asmussen H; Kamaraju AK; Hoenorhoff MJ; Liu ZY; Costes SV; Cho EH; Lockett S; Khanna C; Chambers AF; Green JE
    Cancer Res; 2008 Aug; 68(15):6241-50. PubMed ID: 18676848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Cancer Dormancy and Reactivation in Bone Marrow.
    Singh DK; Patel VG; Oh WK; Aguirre-Ghiso JA
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34208521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation.
    Schmidt JM; Panzilius E; Bartsch HS; Irmler M; Beckers J; Kari V; Linnemann JR; Dragoi D; Hirschi B; Kloos UJ; Sass S; Theis F; Kahlert S; Johnsen SA; Sotlar K; Scheel CH
    Cell Rep; 2015 Jan; 10(2):131-9. PubMed ID: 25578726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications.
    Robinson NJ; Parker KA; Schiemann WP
    Ann Transl Med; 2020 Jul; 8(14):903. PubMed ID: 32793747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription factor Zfp281 controls embryonic stem cell pluripotency by direct activation and repression of target genes.
    Wang ZX; Teh CH; Chan CM; Chu C; Rossbach M; Kunarso G; Allapitchay TB; Wong KY; Stanton LW
    Stem Cells; 2008 Nov; 26(11):2791-9. PubMed ID: 18757296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technical Advancements for Studying Immune Regulation of Disseminated Dormant Cancer Cells.
    Ombrato L; Montagner M
    Front Oncol; 2020; 10():594514. PubMed ID: 33251149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.
    Eyles J; Puaux AL; Wang X; Toh B; Prakash C; Hong M; Tan TG; Zheng L; Ong LC; Jin Y; Kato M; Prévost-Blondel A; Chow P; Yang H; Abastado JP
    J Clin Invest; 2010 Jun; 120(6):2030-9. PubMed ID: 20501944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.